A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

NAActive, not recruitingINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 17, 2021

Study Completion Date

November 30, 2026

Conditions
Mitral Regurgitation FunctionalMitral Valve DiseaseCardiovascular Diseases
Interventions
DEVICE

Millipede Transcatheter Annuloplasty Ring System (Millipede System)

The Millipede Transcatheter Annuloplasty Ring System is a repair device used for treating mitral valve regurgitation (MR). The system consists of several components: a transcatheter annuloplasty ring (implant) which remains in the body and a delivery system and intracardiac echocardiography catheter (imaging device) used to deliver the implant to the mitral valve.

Trial Locations (4)

3168

Monash Health, Clayton

10032

Columbia University Medical Center/New York Presbyterian Hospital, New York

10467

Montefiore Medical Center, The Bronx

85712

Tucson Medical Center Healthcare, Tucson

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY